Parametric Portfolio Associates’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.09M | Sell |
2,492
-965
| -28% | -$422K | ﹤0.01% | 2743 |
|
|
2021
Q4 | $1.52M | Sell |
3,457
-1,800
| -34% | -$789K | ﹤0.01% | 2606 |
|
|
2021
Q3 | $2.92M | Buy |
5,257
+1,870
| +55% | +$1.04M | ﹤0.01% | 2181 |
|
|
2021
Q2 | $1.74M | Buy |
3,387
+1,739
| +106% | +$893K | ﹤0.01% | 2506 |
|
|
2021
Q1 | $1.29M | Buy |
1,648
+199
| +14% | +$156K | ﹤0.01% | 3038 |
|
|
2020
Q4 | $789K | Sell |
1,449
-892
| -38% | -$486K | ﹤0.01% | 3167 |
|
|
2020
Q3 | $1.07M | Sell |
2,341
-4
| -0.2% | -$1.83K | ﹤0.01% | 2887 |
|
|
2020
Q2 | $1.44M | Buy |
2,345
+556
| +31% | +$342K | ﹤0.01% | 2709 |
|
|
2020
Q1 | $851K | Buy |
1,789
+469
| +36% | +$223K | ﹤0.01% | 2881 |
|
|
2019
Q4 | $766K | Sell |
1,320
-1,019
| -44% | -$591K | ﹤0.01% | 3196 |
|
|
2019
Q3 | $1.54M | Buy |
2,339
+1,414
| +153% | +$930K | ﹤0.01% | 2800 |
|
|
2019
Q2 | $716K | Buy |
925
+19
| +2% | +$14.7K | ﹤0.01% | 3211 |
|
|
2019
Q1 | $640K | Sell |
906
-85
| -9% | -$60K | ﹤0.01% | 3226 |
|
|
2018
Q4 | $464K | Buy |
991
+59
| +6% | +$27.6K | ﹤0.01% | 3348 |
|
|
2018
Q3 | $803K | Sell |
932
-61
| -6% | -$52.6K | ﹤0.01% | 3214 |
|
|
2018
Q2 | $685K | Buy |
993
+6
| +0.6% | +$4.14K | ﹤0.01% | 3218 |
|
|
2018
Q1 | $440K | Sell |
987
-19
| -2% | -$8.47K | ﹤0.01% | 3407 |
|
|
2017
Q4 | $443K | Buy |
1,006
+75
| +8% | +$33K | ﹤0.01% | 3391 |
|
|
2017
Q3 | $459K | Sell |
931
-1,435
| -61% | -$707K | ﹤0.01% | 3466 |
|
|
2017
Q2 | $1.31M | Sell |
2,366
-383
| -14% | -$212K | ﹤0.01% | 2820 |
|
|
2017
Q1 | $1.82M | Buy |
2,749
+1,146
| +71% | +$759K | ﹤0.01% | 2504 |
|
|
2016
Q4 | $536K | Buy |
+1,603
| New | +$536K | ﹤0.01% | 3150 |
|